Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Darunavir

An HIV protease inhibitor approved in the United States in 2006. It is used in combination with other antiretrovirals, including as first-line therapy for HIV infection. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines, other impurities and synthesis intermediates.

Did you know?Chemist Arun Ghosh designed it to grip the backbone of the viral protease, a region that changes little when the virus mutates: this keeps it active against many resistant strains.

DarunavirGo to the active ingredient →
DarunavirActive ingredientDarunavirCat. No. P-D022-001CAS 206361-99-1
Darunavir-d9Isotopically labelledDarunavir-d9Cat. No. P-D022-006CAS 1133378-37-6
D-DarunavirImpurityD-DarunavirCat. No. P-D022-020CAS 1399859-60-9

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.